Evidence map›Paper›PMID 23707382›Full record

ArticleJournal of molecular biology2013

Partitioning RS domain phosphorylation in an SR protein through the CLK and SRPK protein kinases.

Brandon E Aubol, Ryan M Plocinik, Jonathan C Hagopian, Chen-Ting Ma, Maria L McGlone, Reeti Bandyopadhyay, Xiang-Dong Fu, Joseph A Adams

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Review
  3. Non-Enzymatic MGO-Glycation of SRSF2 Drives RNA Mis-Splicing.Journal of the American Chemical Society · 2026
    Article
  4. Review
  5. RNA Splicing as a Therapeutic Target in Cancer.Annual review of pharmacology and toxicology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Tumor-promoting effect and tumor immunity of SRSFs.Frontiers in cell and developmental biology · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Brandon E AubolDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0636, USA.
Ryan M Plocinik
Jonathan C Hagopian
Chen-Ting Ma
Maria L McGlone
Reeti Bandyopadhyay
Xiang-Dong Fu
Joseph A Adams
University of California, San Diego · US

Funding

GRADUATE TRAINING IN CELLULAR &MOLECULAR PHARMACOLOGYT32GM007752 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROWN, JOAN HELLER, HANDEL, TRACY M · 1985 to 2023
$13.5M
Role of protein phosphorylation in RNA splicingR01GM067969 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADAMS, JOSEPH · 2004 to 2024
$6.4M
Regulation of RNA metabolism and cell growth control by SR protein kinasesR01GM052872 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DOWDY, STEVEN F · 1996 to 2019
$5.4M
Clk Kinases and Splicing RegulationR01GM098528 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ADAMS, JOSEPH · 2012 to 2019
$2.5M
Mechanism of SR Protein Binding to the Splicing Kinase SRPK1F32GM090484 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PLOCINIK, RYAN MATTHEW · 2010 to 2011
$107k
NIGMS NIH HHS F32 GM090484NIGMS NIH HHS GM07752NIGMS NIH HHS GM090484NIGMS NIH HHS GM67969NIGMS NIH HHS GM98528NIGMS NIH HHS R01 GM052872NIGMS NIH HHS R01 GM067969NIGMS NIH HHS R01 GM098528NIGMS NIH HHS T32 GM007752
6 · The paper itself

Abstract

SR proteins are essential splicing factors whose biological function is regulated through phosphorylation of their C-terminal RS domains. Prior studies have shown that cytoplasmic-nuclear translocalization of the SR protein SRSF1 is regulated by multisite phosphorylation of a long Arg-Ser repeat in the N-terminus of the RS domain while subnuclear localization is controlled by phosphorylation of a shorter Arg-Ser repeat along with several Ser-Pro dipeptides in the C-terminus of the RS domain. To better understand how these two kinases partition Arg-Ser versus Ser-Pro specificities, we monitored the phosphorylation of SRSF1 by CLK1 and SRPK1. Although SRPK1 initially binds at the center of the RS domain phosphorylating in an orderly, N-terminal direction, CLK1 makes widespread contacts in the RS domain and generates multiple enzyme-substrate complexes that induce a random addition mechanism. While SRPK1 rapidly phosphorylates N-terminal serines, SRPK1 and CLK1 display similar activities toward Arg-Ser repeats in the C-terminus, suggesting that these kinases may not separate function in a strict linear manner along the RS domain. CLK1 induces a unique gel shift in SRSF1 that is not the result of enhanced Arg-Ser phosphorylation but rather is the direct result of the phosphorylation of several Ser-Pro dipeptides. These prolines are important for binding and phosphorylation of the SR protein by CLK1 but not for the SRPK1-dependent reaction. The data establish a new view of SR protein regulation in which SRPK1 and CLK1 partition activities based on Ser-Pro versus Arg-Ser placement rather than on N- and C-terminal preferences along the RS domain.

Indexed as

Protein Processing, Post-TranslationalElectrophoretic Mobility Shift AssayHumansModels, BiologicalNuclear ProteinsPhosphorylationProtein Serine-Threonine KinasesProtein-Tyrosine KinasesRNA-Binding ProteinsSerine-Arginine Splicing FactorsClk dual-specificity kinasesNuclear ProteinsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesRNA-Binding ProteinsSerine-Arginine Splicing FactorsSRPK1 protein, humanbovine serum albuminBSACdc2-like kinaseCLKkinasekineticsNational Institutes of HealthNIHphosphorylationRNA recognition motifRRMsplicingSRPKSR proteinSR-specific protein kinase

Identifiers

PMID23707382
PMCPMC3860265
OpenAlexW2066779117

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.